Checkpoint Therapeutics, Inc. (CKPT)

NASDAQ: CKPT · IEX Real-Time Price · USD

1.670

-0.020 (-1.18%)

At close: Apr 17, 2024, 4:00 PM

1.730

+0.060 (3.59%)

Pre-market: Apr 18, 2024, 8:00 AM EDT

Checkpoint Therapeutics Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Year	Current	2023	2022	2021	2020	2019	2018	2017	2016	2015
Market Capitalization	58	54	48	261	180	66	62	99	-	-
Market Cap Growth	-	13.34%	-81.76%	44.83%	173.65%	6.09%	-37.39%	-	-	-
Enterprise Value	53	49	35	206	139	40	40	80	-35	-48
PE Ratio	-1.04	-1.04	-0.76	-4.60	-7.79	-2.66	-1.70	-4.36	-	-
PS Ratio	567.25	523.05	247.57	972.14	168.28	38.49	17.67	57.37	-	-
PB Ratio	-4.13	-4.13	-2.44	8.76	5.09	3.49	5.25	6.58	-	-
P/FCF Ratio	-1.13	-1.13	-0.83	-9.90	-10.87	-3.08	-2.40	-6.40	-	-
P/OCF Ratio	-1.13	-1.13	-0.83	-9.90	-10.87	-3.08	-2.40	-6.40	-	-
EV/Sales Ratio	519.41	475.21	184.71	767.91	130.14	23.22	11.40	46.23	-13.65	-81.27
EV/EBITDA Ratio	-0.94	-0.94	-0.57	-3.63	-6.03	-1.60	-1.10	-3.52	1.59	3.51
EV/EBIT Ratio	-0.94	-0.94	-0.57	-3.63	-6.03	-1.60	-1.10	-3.52	1.59	3.51
EV/FCF Ratio	-1.03	-1.03	-0.62	-7.82	-8.41	-1.86	-1.55	-5.16	3.53	43.28
Debt / Equity Ratio	-	-	-	-	-	-	-	-	-	0.05
Debt / EBITDA Ratio	-	-	-	-	-	-	-	-	-	-0.18
Debt / FCF Ratio	-	-	-	-	-	-	-	-	-	-2.23
Quick Ratio	0.27	0.27	0.37	2.11	5.65	3.22	1.80	3.07	9.78	28.20
Current Ratio	0.29	0.29	0.41	2.15	5.90	3.32	1.90	3.36	9.80	28.30
Asset Turnover	0.02	0.02	0.01	0.00	0.03	0.10	0.12	0.06	0.06	0.02
Interest Coverage	-	-	-	-	-	-	-	-	-64.29	-58.11
Return on Equity (ROE)	267.50%	267.50%	-3651.50%	-120.10%	-89.80%	-250.90%	-171.10%	-102.40%	-57.10%	-59.90%
Return on Assets (ROA)	-950.00%	-950.00%	-227.90%	-92.80%	-70.40%	-138.20%	-120.10%	-83.00%	-51.90%	-54.90%
Return on Capital (ROIC)	399.69%	399.69%	299.40%	-190.69%	-65.58%	-131.85%	-311.20%	-151.42%	-68.61%	-27.06%
Earnings Yield	-88.74%	-96.24%	-131.75%	-21.75%	-12.83%	-37.59%	-58.69%	-22.91%	-	-
FCF Yield	-81.45%	-88.33%	-121.08%	-10.10%	-9.20%	-32.51%	-41.64%	-15.62%	-	-
Buyback Yield / Dilution	-112.13%	-112.13%	-16.21%	-36.18%	-58.14%	-23.64%	-26.24%	-4.99%	-118.60%	-
Total Shareholder Return	-112.13%	-112.13%	-16.21%	-36.18%	-58.14%	-23.64%	-26.24%	-4.99%	-118.60%	-

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).